Beckman Coulter

Beckman Coulter is an American biomedical testing company whose products support clinical laboratories, hospitals, biotechnology companies, pharmaceutical manufacturers, academic researchers, and other life-science organizations. Its business is organized around two closely related areas: Beckman Coulter Diagnostics, which supplies clinical laboratory systems and reagents, and Beckman Coulter Life Sciences, which serves research and bioprocessing markets with analytical instruments, flow cytometry platforms, centrifuges, cell-analysis systems, liquid-handling technologies, and associated consumables. The company originated in 1935 when California Institute of Technology professor Arnold O. Beckman established National Technical Laboratories to commercialize a pH meter of his own invention. That instrument helped bring precise electronic measurement into industrial and scientific laboratories. During the 1940s, the business expanded its portfolio to include oxygen analyzers, precision potentiometers, and spectrophotometers, and it adopted names associated with its founder before becoming Beckman Instruments. The company went public in 1952 and subsequently broadened its laboratory-technology position through internal development and acquisitions. A major early expansion came in 1954 with the purchase of Specialized Instruments Corporation, known as Spinco. Spinco became the source of a substantial centrifuge business and helped establish Beckman as a supplier of equipment used in biochemical and life-science research. Beckman also developed the EASE family of analog computers in the 1950s; two systems were later used by NASA for real-time simulation work connected with development of the Apollo Guidance Computer. These activities reflected the company's long-standing combination of precision instrumentation, electronics, and biomedical applications. Beckman Instruments entered a period of corporate change in the 1980s. It merged with SmithKline in 1982 to form SmithKline Beckman, but regained independence in 1989 after the SmithKline and Beecham combination. The independent company pursued growth through acquisitions, including Hybritech in 1985 and Sanofi's laboratory diagnostics business in 1996. In 1998, it acquired Coulter Corporation, whose technology was based on Wallace H. Coulter's particle-counting and cell-analysis inventions. The combined organization adopted the Beckman Coulter name, joining Beckman's analytical-instrument heritage with Coulter's strong position in hematology and cellular diagnostics. The acquisition of Olympus Corporation's laboratory diagnostics business in 2009 further expanded Beckman Coulter's clinical laboratory portfolio. Around the same period, the company moved its world headquarters from Fullerton to a renovated facility in nearby Brea, California. Danaher announced an agreement to acquire Beckman Coulter in 2011 and completed the transaction on June 30 of that year. Under Danaher, Beckman Coulter was reorganized into Diagnostics and Life Sciences operating units, with Diagnostics headquartered in Brea and Life Sciences based in Indianapolis, Indiana. The Danaher era has continued Beckman Coulter's emphasis on laboratory workflow integration, automation, and acquisitions. In 2012, Danaher acquired IRIS International and its Iris Diagnostics business, strengthening capabilities in urinalysis. In 2022, Beckman Coulter Life Sciences acquired ValitaCell, an Ireland-based biotechnology company whose analytical products are used in biopharmaceutical development. In 2025, Life Sciences entered a strategic collaboration with Swiss automation specialist Hombrechtikon Systems Engineering to support integration of nucleic-acid quantification into automated liquid-handling workflows. Today, Beckman Coulter operates as a global Danaher subsidiary rather than as an independently listed company. Its brand covers technologies ranging from routine chemistry, immunoassay, hematology, urinalysis, and…

Beckman Coulter traces its origins to 1935, when Arnold O. Beckman founded National Technical Laboratories to commercialize an electronic pH meter. Beckman, a Caltech professor, developed the instrument to make chemical measurement more precise and practical in industrial and scientific settings. The company later expanded into oxygen analyzers, precision potentiometers, and spectrophotometers. During the 1940s it used names associated with Beckman before becoming Beckman Instruments, and it became a publicly traded company in 1952. The company strengthened its research-instrument position in 1954 by acquiring Specialized Instruments Corporation, commonly known as Spinco. Spinco became an important source of centrifugation products, including equipment used in biochemical and biomedical research. Beckman also developed the EASE series of analog computers during the 1950s. Two of these systems were used by NASA during the 1960s for real-time simulation associated with the development of the Apollo Guidance Computer, illustrating the company's broader involvement in precision instrumentation and advanced engineering. Corporate ownership changed substantially in the 1980s. Beckman Instruments merged with SmithKline in 1982 to create SmithKline Beckman, with Arnold Beckman serving as vice chairman. After SmithKline combined with Beecham Group in 1989, Beckman regained independence. The independent company then expanded by acquisition. It purchased Hybritech from Eli Lilly in 1985 and acquired Sanofi's laboratory diagnostics business in 1996. These transactions increased its presence in clinical testing and biotechnology-related markets. In 1998, Beckman acquired Coulter Corporation, a company founded by Wallace H. Coulter. Coulter's particle-counting technology, commonly associated with the Coulter counter, had become particularly influential in hematology and cellular analysis. The merger produced the Beckman Coulter name and combined Beckman's analytical and laboratory-instrument heritage with Coulter's diagnostic and cell-analysis capabilities. Beckman Coulter continued to expand its clinical diagnostics portfolio through the acquisition of Olympus Corporation's laboratory diagnostics business in 2009. The company also moved its world headquarters from Fullerton, California, to a renovated facility in Brea. In February 2011, Danaher announced a definitive agreement to acquire Beckman Coulter, and the transaction closed on June 30, 2011. Following the acquisition, Danaher reorganized the business into Beckman Coulter Diagnostics, headquartered in Brea, and Beckman Coulter Life Sciences, based in Indianapolis, Indiana. The post-acquisition organization continued to grow through related acquisitions and partnerships. In 2012, Danaher acquired IRIS International and its Iris Diagnostics business, strengthening urinalysis capabilities. In 2022, Beckman Coulter Life Sciences acquired ValitaCell, an Irish biotechnology company offering analytical products used in biopharmaceutical development. In 2025, Life Sciences established a collaboration with Hombrechtikon Systems Engineering AG of Switzerland to connect nucleic-acid quantification with automated liquid-handling workflows. Beckman Coulter now operates as a Danaher subsidiary serving clinical laboratories, hospitals, research institutions, biotechnology companies, pharmaceutical manufacturers, and bioprocessing organizations. Its portfolio spans chemistry, immunoassay, hematology, urinalysis, flow cytometry, centrifugation, cell analysis, laboratory automation, and research and biopharmaceutical analytical systems. The company’s development has been characterized by a progression from precision measurement instruments to integrated laboratory platforms that combine hardware, reagents, software, automation, consumables, and service.

1. 2025Automation collaboration with HSE

   Beckman Coulter Life Sciences collaborates with Hombrechtikon Systems Engineering on automated liquid-handling workflows incorporating nucleic-acid quantification.

   Source
2. 2022ValitaCell is acquired

   Beckman Coulter Life Sciences acquires ValitaCell to expand analytical capabilities for biopharmaceutical development.

   Source
3. 2012IRIS International joins the diagnostics portfolio

   Danaher's acquisition of IRIS International strengthens urinalysis capabilities associated with Beckman Coulter's diagnostics business.

   Source
4. 2011Danaher acquisition closes

   Danaher completes its acquisition of Beckman Coulter on June 30, bringing the company into its life-science and diagnostics portfolio.

   Source
5. 2009Olympus laboratory diagnostics business is acquired

   The transaction broadens Beckman Coulter's laboratory diagnostics portfolio and precedes the relocation of its world headquarters to Brea.

   Source
6. 1998Coulter Corporation is acquired

   The acquisition combines Beckman's laboratory instrumentation business with Coulter's hematology and cellular-analysis technologies, leading to the Beckman Coulter name.

   Source
7. 1989Beckman regains independence

   Following the SmithKline and Beecham combination, Beckman separates and resumes operation as an independent company.

   Source
8. 1982Merger with SmithKline

   Beckman Instruments merges with SmithKline to form SmithKline Beckman.

   Source
9. 1954Spinco acquisition expands centrifugation

   Beckman Instruments acquires Specialized Instruments Corporation, creating a stronger position in laboratory centrifuges and research equipment.

   Source
10. 1952Beckman Instruments becomes publicly traded

    The company adopts the Beckman Instruments name before entering the public market.

    Source
11. 1935National Technical Laboratories is founded

    Arnold O. Beckman establishes National Technical Laboratories to commercialize his electronic pH meter.

    Source

A global laboratory-technology supplier focused on integrated clinical diagnostics, biomedical research, bioprocess analytics, automation, and high-throughput laboratory workflows.

• Clinical Chemistry SystemsIn-vitro diagnostics

  Clinical chemistry analyzers and reagent systems measure chemical components in patient specimens. They are designed for routine and high-throughput laboratory testing and are commonly integrated with sample-handling, information-management, and broader laboratory-automation workflows.

• Immunoassay SystemsIn-vitro diagnostics

  Immunoassay platforms use antibody-based methods to detect and quantify clinically relevant substances. Beckman Coulter supplies analyzers, reagent systems, and related workflow components for hospital and reference laboratories.

• Hematology and Coulter Cell-Analysis SystemsIn-vitro diagnostics1998

  These systems support blood-cell counting, classification, and related hematology testing. They reflect the Coulter technology heritage brought into Beckman Coulter through the 1998 acquisition of Coulter Corporation and form an important part of the company's clinical diagnostics portfolio.

• Urinalysis SystemsIn-vitro diagnostics2012

  Urinalysis instruments and consumables support chemical and microscopic examination of urine specimens. The business was strengthened through Danaher's 2012 acquisition of IRIS International and its Iris Diagnostics operation.

• Flow Cytometry PlatformsLife-science research

  Flow cytometry instruments and reagents analyze physical and fluorescent characteristics of cells or particles as they pass through an instrument. They are used in immunology, cell biology, cancer research, drug discovery, and related biomedical applications.

• Laboratory CentrifugesLife-science research1954

  Beckman Coulter's centrifugation line descends from the Spinco business acquired in 1954. The products support separation and preparation of biological samples across research, clinical, industrial, and bioprocessing laboratories.

• Laboratory Automation and Liquid HandlingLaboratory automation

  Automation systems connect instruments, sample handling, liquid movement, software, and analytical steps to improve laboratory throughput and reproducibility. The Life Sciences business has also pursued integration of nucleic-acid quantification with automated liquid-handling workflows.

• Biopharmaceutical Analytical SolutionsBiotechnology2022

  These instruments, assays, and analytical tools support biopharmaceutical development and process characterization. The portfolio was expanded through the acquisition of ValitaCell, whose products are used in biotechnology and bioprocess development.

• 2025Integrate nucleic-acid quantification with automationStrategy

  Laboratories increasingly seek connected workflows that combine liquid handling, sample preparation, and analytical measurement.

  What changed. Beckman Coulter Life Sciences established a strategic collaboration with Hombrechtikon Systems Engineering AG to integrate nucleic-acid quantification into automated liquid-handling workflows.

  Aftermath. The collaboration supports a more integrated automation proposition for molecular biology and bioprocessing laboratories.

  Source
• 2022Acquire ValitaCellM&A

  ValitaCell provided analytical products relevant to biotechnology and biopharmaceutical development.

  What changed. Beckman Coulter Life Sciences acquired the Ireland-based biotechnology company.

  Aftermath. The acquisition expanded Life Sciences' capabilities in biopharmaceutical analytical workflows.

  Source
• 2012Add IRIS International and Iris DiagnosticsM&A

  Danaher pursued additional diagnostic capabilities after acquiring Beckman Coulter, with urinalysis identified as a complementary area.

  What changed. Danaher acquired IRIS International and its Iris Diagnostics business.

  Aftermath. The transaction strengthened the urinalysis component of the broader Beckman Coulter-related diagnostics portfolio.

  Source
• 2011Join Danaher CorporationM&A

  Danaher sought to expand its diagnostics and life-science activities through the acquisition of Beckman Coulter.

  What changed. Danaher announced a definitive agreement in February and completed the acquisition on June 30, 2011.

  Aftermath. Beckman Coulter became a Danaher subsidiary and was reorganized into Diagnostics and Life Sciences operating units.

  Source
• 1998Acquire Coulter CorporationM&A

  Coulter Corporation brought established particle-counting, hematology, and cellular-analysis capabilities that complemented Beckman's analytical-instrument business.

  What changed. Beckman acquired Coulter Corporation and adopted the Beckman Coulter identity for the combined business.

  Aftermath. The transaction created a broader diagnostics and life-science company with a substantial position in hematology and cell analysis.

  Source

• 2025Beckman Coulter Life Sciences establishes automation collaboration with HSE

  Beckman Coulter Life Sciences formed a strategic collaboration with Hombrechtikon Systems Engineering to integrate nucleic-acid quantification into automated liquid-handling workflows.

  Product launch
  Source
• 2022Beckman Coulter Life Sciences acquires ValitaCell

  ValitaCell, an Ireland-based biotechnology company, joined Beckman Coulter Life Sciences, adding analytical capabilities relevant to biopharmaceutical development.

  M&A
  Source
• 2012Danaher acquires IRIS International and Iris Diagnostics

  The acquisition expanded Danaher's diagnostics capabilities within the Beckman Coulter-related portfolio, particularly in urinalysis.

  M&AProduct generation
  Source
• 2011Danaher announces agreement to acquire Beckman Coulter

  Danaher announced a definitive agreement to acquire Beckman Coulter, beginning the transaction that would bring the diagnostics and life-science company into the Danaher group.

  M&A
  Source
• 2011Danaher completes acquisition of Beckman Coulter

  The acquisition was completed on June 30, 2011. Beckman Coulter subsequently operated as a Danaher subsidiary and was organized into Diagnostics and Life Sciences business units.

  M&A
  Source

1. Beckman Coulter
2. Beckman Coulter corporate website